Human Recombinant MIP-4, STEMCELL Technologies (CAT#: STEM-CT-0753-ZJF)

Macrophage inflammatory protein-4 (MIP-4) plays a role in adaptive and innate immune responses, acting as a chemoattractant for T and B lymphocytes, and natural killer cells (Krohn et al.). MIP-4 can also induce immune tolerance through its effects on dendritic cells and macrophages (Azzaoui et al., Schraufstatter et al.). In breast cancer, MIP-4 has been shown to promote the invasiveness and metastasis of cancer cells in vivo by binding PITPNM3 (Chen et al.).This small cytokine belongs to the chemokine family found only in primates. Based on amino acid sequence, MIP-4 is closely related to MIP-1 alpha (CCL3) and MIP-1 beta (CCL4) (Liang et al.). MIP-4 is produced by antigen-presenting immune cells including dendritic cells, macrophages, and monocytes (Lieshout et al.). For consistency and reproducibility across your applications, macrophage inflammatory protein-4 from STEMCELL comes lyophilized with ≥ 95% purity, and is verified by LAL analysis to ensure endotoxin levels are ≤ 1.0 EU/μg protein.

Subtype: Cytokines
Alternatives Names: AMAC-1, CCL18, DC-CK1, PARC
Species: Human
Area of Interest: Metabolism
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant IFN alpha 1, STEMCELL Technologies
Human Recombinant Visfatin, STEMCELL Technologies
Human Recombinant Fetuin B, STEMCELL Technologies
Human Recombinant Apolipoprotein H, STEMCELL Technologies